Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Therapeutics III > Tisdale Arrhythmia > Flashcards

Tisdale Arrhythmia Flashcards

1
Q

What is torsades de pointes?

A

-When the QTc interval is 500 ms or more, there is an increased risk
-Torsades de pointes can cause sudden cardiac death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of supraventricular arrhythmias

A

-Sinus bradycardia
-Atrioventricular (AV) block
-Sinus tachycardia
-Atrial fibrillation
-Supraventricular tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of ventricular arrhythmias

A

-Premature ventricular complexes (PVCs)
-Ventricular tachycardia
-Ventricular fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is sinus bradycardia?

A

-Heart rate less than 60 beats per minute
-Impulses originating in sinoatrial node
-Decreased automaticity of the SA node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sinus bradycardia risk factors

A

-Myocardial infarction or ischemia
-Abnormal sympathetic or parasympathetic tone
-Hyperkalemia
-Hypermagnesemia
-Beta blockers
-CCBs
-Amiodarone
-Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Symptoms of sinus bradycardia

A

-Hypotension
-Dizziness
-Syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment of sinus bradycardia

A

-Only if patient is symptomatic
-Atropine 0.5-1 mg IV, repeat every 5 minutes
-Maximum dose 3 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What to do if patient is unresponsive to atropine

A

-Transcutaneous pacing (pacemaker on the skin)
-Dopamine 5-20 mcg/kg/min
-Epinephrine 2-10 mcg/min or 0.1-0.5 mcg/kg/min
-Isoproterenol 20-60 mcg IV bolus followed by doses of 10-20 mcg or infusion of 1-20 mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adverse effects of atropine

A

-Tachycardia
-Urinary retention
-Blurred vision
-Dry mouth
-Mydriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment of sinus bradycardia after heart transplant or spinal cord injury

A

-Aminophylline 6 mg/kg IV over 20-30 minutes
-Theophylline heart transplant: 300 mg IV followed by oral dose of 5-10 mg/kg/day titrated to effect
-Theophylline spinal cord injury: oral dose of 5-10 mg/kg/day titrated to effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Long term treatment of sinus bradycardia

A

-Some patients may require a pacemaker
-For patients unwilling to undergo implantation of a permanent pacemaker: theophylline oral 5-10 mg/kg/day titrated to effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of atrial fibrillation

A

-Atrial activity: chaotic and disorganized - no atrial depolarizations
-Ventricular rate: 120-180 bpm
-Rhythm: irregularly irregular
-P waves: Absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stage 1 atrial fibrillation

A

Presence of modifiable and nonmodifiable risk factors associated with AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Stage 2 atrial fibrillation

A

-Pre-atrial fibrillation
-Evidence of structural or electrical findings that further predispose patients to AF (Atrial enlargement, frequent atrial premature beats, atrial flutter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stage 3A atrial fibrillation

A

Paroxysmal AF: AF that is intermittent and terminates within 7 days of onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stage 3B atrial fibrillation

A

Persistent AF: AF that is continuous and sustains for more than 7 days and requires intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Stage 3C atrial fibrillation

A

Long-standing persistent AF: AF that is continuous for more than 12 months in duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Stage 3D atrial fibrillation

A

Successful AF ablation: freedom from AF after percutaneous or surgical intervention to eliminate AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Stage 4 atrial fibrillation

A

Permanent trial fibrillation: no further attempts at rhythm control after discussion between the patient and clinician

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanisms of atrial fibrillation

A

-Abnormal atrial/pulmonary vein automaticity
-Atrial reentry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Atrial fibrillation risk factors

A

-Advancing age
-Cigarette smoking
-Sedentary lifestyle
-Alcohol
-Obesity
-Hypertension
-Diabetes mellitus
-Coronary artery disease
-Heart failure
-Obstructive sleep apnea
-Valvular heart disease
-Chronic kidney disease
-Genetic
-Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Etiologies of reversible atrial fibrillation

A

-Hyperthyroidism
-Thoracic surgery (coronary artery bypass graft, lung resection, esophagectomy)
-Sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Atrial fibrillation symptoms

A

-May be asymptomatic
-Palpitations
-Dizziness
-Fatigue
-Lightheadedness
-Shortness of breath
-Hypotension
-Syncope
-Angina (in patients with coronary artery disease)
-Exacerbation of heart failure symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Atrial fibrillation morbidity/mortality risks

A

-Stroke/systemic embolism - risk increased 5x
-Heart failure - risk increased 3x
-Dementia - risk increased 2x
-Mortality - risk increased 2x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How to prevent atrial fibrillation
-Lifestyle and risk factor modification -Physical fitness -Smoking cessation -Minimize or eliminate alcohol consumption -Blood pressure control in patients with hypertension -Optimal glucose and A1C management in patients with diabetes
26
Atrial fibrillation goals of therapy
-Prevent stroke/systemic embolism -Slow ventricular response by inhibiting conduction of impulses to ventricles -Convert atrial fibrillation to normal sinus rhythm -Maintain sinus rhythm (reduce frequency of episodes)
27
When are oral anticoagulants recommended for patients with atrial fibrillation?
-CHADSVASc score of 2 or more in men -CHADSVASc score of 3 or more in women
28
When can oral anticoagulants be omitted in patients with atrial fibrillation?
-CHADSVASc score of 0 in men -CHADSVASc score of 0-1 in women
29
What anticoagulant is preferred in atrial fibrillation?
-DOACs are preferred -Warfarin is preferred over DOACs in patients with a mechanical heart valve and patients with atrial fibrillation associated with heart valve disease -Warfarin or apixaban are preferred in patients with end-stage kidney disease and/or on hemodialysis
30
Drugs for ventricular rate control
-Diltiazem -Verapamil -Esmolol -Propranolol -Metoprolol -Digoxin -Amiodarone
31
How to define hemodynamically unstable
One of the following is true: -Systolic less than 90 -BPM over 150 -Loss of consciousness -Ischemic chest pain
32
How do you treat acute ventricular rate control (AFIB) if the patient is not hemodynamically stable?
Direct current cardioversion
33
How do you treat acute ventricular rate control (AFIB) if the patient is hemodynamically stable and has decompensated heart failure
Amiodarone
34
How do you treat acute ventricular rate control (AFIB) if the patient is hemodynamically stable and does not have decompensated heart failure?
-Beta-blocker, diltiazem, or verapamil -Digoxin -Amiodarone
35
How do you treat long-term ventricular rate control (AFIB) if the LVEF is 40% or less?
-Beta-blocker -Digoxin
36
How do you treat long-term ventricular rate control (AFIB) if the LVEF is over 40%?
-Beta-blocker, diltiazem, or verapamil -Digoxin
37
When is it safe to convert to sinus rhythm?
-If AF has been present for 48 hours or less, conversion to sinus rhythm is safe -If AF has been present for more than 48 hours, conversion to sinus rhythm should not be preformed until patient has been anticoagulated for 3 weeks, or unless a transesophageal echocardiogram (TEE) has been performed to rule out a clot in the atrium
38
How do you convert hemodynamically stable atrial fibrillation patients to sinus rhythm who have normal LV function?
IV amiodarone, ibutilide
39
How do you convert hemodynamically stable atrial fibrillation patients to sinus rhythm who have HFrEF (LVEF 40% or less)?
IV amiodarone
40
How do you convert hemodynamically stable atrial fibrillation patients to sinus rhythm who are not in the hospital and have normal LV function?
Flecainide, propafenone
41
Oral amiodarone adverse effects
-Blue-grey skin discoloration -Photosensitivity -Corneal microdeposits -Pulmonary fibrosis -Hepatotoxicity -Bradycardia -Hype/hyperthyroidism
42
Dofetilide adverse effects
Torsades de pointes
43
How do you dose dofetilide when the creatinine clearance is over 60?
500 mcg orally twice daily
44
How do you dose dofetilide when the creatinine clearance is 40-60?
250 mcg orally twice daily
45
How do you dose dofetilide when the creatinine clearance is 20-39?
125 mcg orally twice daily
46
How do you dose dofetilide when the creatinine clearance is less than 20?
Contraindicated
47
Amiodarone recommended monitoring
-Hypo- or hyperthyroidism: TSH (T3 and T4 if TSH abnormal) -Hepatotoxicity: liver function tests (ALT, AST) -QT interval prolongation: ECG -Pulmonary fibrosis: chest X-ray
48
What to give for maintenance therapy of sinus rhythm following conversion to SR or for paroxysmal AF when the patient has normal LV function, and has no history of a prior MI or significant heart disease
-Dofetilide, dronedarone, flecainide, propafenone -Amiodarone -Sotalol
49
What to give for maintenance therapy of sinus rhythm following conversion to SR or for paroxysmal AF when the patient has a history of prior MI or significant structural heart disease, including HFrEF (LVEF 40% or less)
-Amiodarone, dronedarone, dofetilide -Sotalol
50
What is dronedarone contraindicated in?
NYHA class III or IV or recent decompensated HF
51
When would you adjust dofetilide dose?
Adjust 2-3 hours after first dose - check QTc interval
52
How do you adjust dofetilide dose if QTc increases by 15% or less?
Continue current dose
53
How do you adjust dofetilide dose if QTc increases by more than 15% or to greater than 500 ms?
Decrease dose by 50%
54
How do you adjust dofetilide dose if QTc is over 500 ms after the second dose?
Discontinue dofetilide
55
How do you initiate sotalol therapy?
Place patient on continuous ECG monitoring and proceed only if QTc is 450 ms or less
56
How do you dose sotalol if the patient has CrCl over 60?
80 mg twice daily
57
How do you dose sotalol if the patient has CrCl 40-60?
80 mg once daily
58
When should you check QTc interval after each sotalol/dofetilide dose?
2-4 hours
59
How do you dose sotalol if the patient has QTc less than 500 ms after 3 days?
-Patient can be discharged -Dose can be increased to 120 mg twice daily and patient can be followed for 3 days on this dose
60
How do you dose sotalol if the patient has QTc of 500 ms or more?
Discontinue sotalol
61
When should catheter ablation be used for rhythm control in atrial fibrillation?
In patients whom antiarrhythmic drugs have been ineffective, contraindicated, not tolerated or not preferred
62
When can catheter ablation be used as first-line therapy?
In selected patients (generally younger and with fewer comorbidities) with symptomatic paroxysmal atrial fibrillation
63
What is supraventricular tachycardia?
-Regular rhythm -Narrow QRS complex -Heart rate 110 - >250 beats per minute -Spontaneous initiation and termination -Prevalence: 225 per 100,000 -Incidence: 35 cases per 100,000 persons per year
64
What is paroxysmal SVT?
-A subset of SVT -Intermittent episodes of SVT -Episodes start suddenly and spontaneously, last for minutes to hours, and terminate suddenly and spontaneously
65
Risk factors
-Women have 2x higher risk than men -Age over 65 years have a 5x greater risk than younger people -Often occurs in individuals with no underlying CVD
66
Symptoms of supraventricular tachycardia
-"Neck-pounding" -Palpitations -Dizziness -Weakness -Lightheadedness -Near-syncope -Syncope -Polyuria
67
How do you treat patients to terminate hemodynamically stable SVT?
-Vagal maneuvers and/or IV adenosine -If ineffective or not feasible then give IV beta-blockers or IV diltiazem or IV verapamil -If ineffective or not feasible then give synchronized DCC
68
How do you treat patients for the prevention of recurrence of SVT when the patient is asymptomatic or minimally symptomatic?
Clinical follow-up without treatment
69
How do you treat patients for the prevention of recurrence of SVT when the patient is symptomatic and is a candidate for catheter ablation?
Catheter ablation
70
How do you treat patients for the prevention of recurrence of SVT when the patient is symptomatic, is not a candidate for catheter ablation, and does not have HFrEF?
-Beta-blockers, diltiazem, verapamil -Flecainide, propafenone (CI in CAD) -Catheter ablation if all else fails
71
How do you treat patients for the prevention of recurrence of SVT when the patient is symptomatic, is not a candidate for catheter ablation, and has HFrEF (LVEF less than 40%)?
-Amiodarone, digoxin, dofetilide, sotalol -Catheter ablation if all else fails
72
What are the different types of ventricular arrhythmias?
-Premature ventricular complexes (PVCs) -Ventricular tachycardia -Ventricular fibrillation
73
What are premature ventricular complexes?
-Wide QRS complexes -Low prevalence in healthy population -Prevalence increases with advancing age
74
What are simple premature ventricular complexes?
Isolated single PVCs
75
What are paired premature ventricular complexes?
Couplets, two in a row
76
What are bigeminy PVCs?
Every second beat
77
What are trigeminy PVCs?
Every third beat
78
What are quadrigeminy PVCs?
Every fourth beat
79
Mechanism of PVCs
Increased automaticity of ventricular muscle cells/Purkinje fibers
80
Risk factors for PVC
-Ischemic heart disease -Myocardial infarction -Anemia -Hypoxia -Cardiac surgery
81
Symptoms of PVC
-Usually asymptomatic -Frequent/repetitive PVCs can result in palpitations, dizziness, lightheadedness
82
How to treat asymptomatic PVCs
Asymptomatic PVCs should not be treated
83
How to treat symptomatic PVCs in patients who do not have CAD or HF
-Beta-blockers, diltiazem, or verapamil -If unresponsive - antiarrhythmic drugs
84
How to treat frequent symptomatic PVCs (>15% of beats) in patients who are unresponsive to beta-blockers, CCBs or antiarrhythmic drugs
Catheter ablation
85
How to treat symptomatic PVCs in patients who have CAD
-Beta-blockers, diltiazem, or verapamil -If unresponsive - antiarrhythmic drugs
86
How to treat symptomatic PVCs in patients who have HF
Beta-blockers
87
What is ventricular tachycardia?
-Regular rhythm -Wide QRS complexes -Defined as a series of 3 or more consecutive PVCs at a rate of over 100 bpm
88
Types of ventricular tachycardia
-Nonsustained -Sustained
89
What is nonsustained ventricular tachycardia?
3 or more consecutive VPDs, terminates spontaneously
90
What is sustained ventricular tachycardia?
-VT lasting more than 30 seconds -Requires termination because of hemodynamic instability in less than 30 seconds
91
What is sustained monomorphic VT in patients with no structural heart disease known as?
Idiopathic VT
92
What is idiopathic VT sometimes responsive to?
Verapamil
93
Ventricular tachycardia mechanism
-Increased ventricular automaticity -Reentry
94
Risk factors of ventricular tachycardia
-Coronary artery disease -Myocardial infarction -HFrEF -Electrolyte abnormalities (hypokalemia, hypomagnesemia) -Flecainide -Propafenone -Digoxin
95
Symptoms of ventricular tachycardia
-May be asymptomatic (nonsustained VT) -Palpitations -Hypotension -Dizziness -Lightheadedness -Syncope -Angina
96
What is the class 1 treatment to terminate VT in a patient with structural heart disease?
DCC
97
What is the class 2a treatment to terminate VT in a patient with structural heart disease?
IV procainamide
98
What is the class 2b treatment to terminate VT in a patient with structural heart disease?
IV amiodarone or IV sotalol
99
What do you do when VT is terminated after the first treatment in a patient with structural heart disease?
Give therapy to prevent recurrence guided by underlying heart disease
100
What do you do when VT is not terminated after the first treatment in a patient with structural heart disease?
DCC
101
How do you treat verapamil-sensitive VT in a patient who does not have structural heart disease?
Verapamil
102
How do you treat outflow tract VT in a patient who does not have structural heart disease?
beta-blocker
103
What do you do when VT is terminated after the first treatment in a patient without structural heart disease?
Therapy to prevent recurrence
104
What do you do when VT is not terminated after the first treatment in a patient without structural heart disease?
DCC
105
What therapy is used to prevent recurrence of VT and sudden cardiac death?
-Implantable cardioverter-defibrillator -Amiodarone -Sotalol -Catheter ablation
106
What is ventricular fibrillation
-Irregular, disorganized, chaotic electrical activity -No recognizable QRS complexes
107
Risk factors of ventricular fibrillation
-Myocardial infarction -HFrEF -Coronary artery disease
108
Symptoms of ventricular fibrillation
Syndrome of sudden cardiac death
109
How do you terminate VT (or VT with no pulse)
-CPR for 2 minutes and obtain IV/IO access -Defibrillation shock -CPR for 2 minutes -Epinephrine 1 mg IV/IO -Defibrillation shock -CPR for 2 minutes -Amiodarone 300 mg IV/IO or lidocaine 1-1.5 mg/kg IV/IO -After first dose of amio/lidocaine, every subsequent dose should be halved -CPR should be occurring throughout the entire duration -Continue pattern of defibrillation, shock, then CPR for 2 minutes, then epinephrine 1 mg IV every 3-5 minutes until patient is resuscitated or resuscitation attempt is terminated

Therapeutics III (42 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions